Outsourced Pharma White Papers

  1. Solving The AAV Scalability Challenge 12/18/2024

    Explore the effectiveness of a flexible, scalable AAV manufacturing platform that incorporates well-characterized bioreactors and advanced production systems to drive the development of cost-effective, high-quality gene therapies.

  2. The Advantages Of A Blended Learning Approach In Operator Training 5/30/2024

    Explore blended learning and its advantages over traditional operator training methods, which often reduce training to a repetitive but necessary checklist of reading and acknowledging procedures.

  3. A Molecule's Journey: Break Down Roadblocks To Clinical Success 7/13/2023

    The key to a biopharma executive's success is making the right decisions at the right time. Which will get your biologic to the clinic quickly and cost-effectively, without compromising quality and patient safety?

  4. Mastering Technology Transfers: Our Blueprint For Success 4/16/2025

    Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

  5. Metabolite And Nutrient Analysis As Crucial Components For Optimal Upstream Process 2/8/2024

    Discover how insights into cell metabolism can further enable the development of efficient cell culture processes through tailored nutrient supplementation and monitoring.

  6. Inspecting On The Edge — Understanding Punch Tip Wear 7/30/2024

    Why is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?

  7. The Role Of The Technical Transfer Executive Sponsor 10/30/2023

    Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.

  8. CGMP-Validated RCL Assay Used For Release Testing Of Manufactured Viruses, Gene Mediated Cell Therapy Products 3/5/2025

    Ensure the safety and efficacy of lentiviral-based therapies by addressing the risks of replication-competent lentiviruses (RCLs) through advanced monitoring and control strategies.

  9. Accelerating ADC Clinical Development Timelines 8/28/2024

    For ADC developers, obtaining the desired payload can be a challenge, as their synthesis is more complex than most other small molecules. Learn about a more efficient approach to payload synthesis.

  10. Quality By Design: The Importance Of Reference Standards In Drug Development 8/1/2024

    Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.